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Background
The biological cardiac prosthesis on the market today,
are durable and functional, but still not the ideal valve
replacement in children.
Objectives
Develop three different models of polyurethane prostheses
prototypes for substitution in cardiac valve disease and
remodeling of the right ventricle, in patients with congeni-
tal heart disease.
Methods
Based on a computed tomography angiography of the
aorta, we made a delrin ring, keeping the anatomical
characteristics of the aortic annulus. A matrix one follow-
ing we made from stainless steel with the shape of the
three cusp aortic valve, followed by preparation of the
injection of liquid polyurethane segmented (SPU), using
a esterolitografia technique. In vitro tests: The materials
used in the manufacture of prostheses were approved in
biocompatibility testing according to ISO 10993 - Biolo-
gical evaluation of medical devices. The dentures will
undergo physical tests, hydrodynamic and durability
according to ISO 5840 - Cardiovascular Implants - Pros-
thetic heart valves.
Results
The macroscopic appearance of these prototypes was
approved by the group of Engineer, Biologist and Pediatric
Cardiac Surgeon. It will be observed the macroscopic and
microscopic optical and electronic scanning and imaging
studies. The data will be sorted by making emphasis on
the degree of calcification, presence of thrombi, infection
and integrity of the prosthesis SPU. Experimental studies
published showed good hemodynamic performance of the
polyurethane prostheses, implanted on the right side of
the heart: the absence of significant pressure gradients.
Conclusions
It is possible to reproduce these results and further
studies, carried out to better understand the properties of
the SPU and level of reliability with a view on release,
compared to health authorities for clinical application,
thus becoming one more option among the prostheses on
the market today.
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